242 related articles for article (PubMed ID: 25660822)
1. Lactobacillus paracasei F19 versus placebo for the prevention of proton pump inhibitor-induced bowel symptoms: a randomized clinical trial.
Compare D; Rocco A; Sgamato C; Coccoli P; Campo SM; Nazionale I; Larussa T; Luzza F; Chiodini P; Nardone G
Dig Liver Dis; 2015 Apr; 47(4):273-9. PubMed ID: 25660822
[TBL] [Abstract][Full Text] [Related]
2. Long-term treatment with probiotics in primary care patients with irritable bowel syndrome--a randomised, double-blind, placebo controlled trial.
Begtrup LM; de Muckadell OB; Kjeldsen J; Christensen RD; Jarbøl DE
Scand J Gastroenterol; 2013 Oct; 48(10):1127-35. PubMed ID: 23957590
[TBL] [Abstract][Full Text] [Related]
3. Effects of probiotic fermented milk on symptoms and intestinal flora in patients with irritable bowel syndrome: a randomized, placebo-controlled trial.
Søndergaard B; Olsson J; Ohlson K; Svensson U; Bytzer P; Ekesbo R
Scand J Gastroenterol; 2011 Jun; 46(6):663-72. PubMed ID: 21443416
[TBL] [Abstract][Full Text] [Related]
4. Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Yoon JS; Sohn W; Lee OY; Lee SP; Lee KN; Jun DW; Lee HL; Yoon BC; Choi HS; Chung WS; Seo JG
J Gastroenterol Hepatol; 2014 Jan; 29(1):52-9. PubMed ID: 23829297
[TBL] [Abstract][Full Text] [Related]
5. Effects of long-term PPI treatment on producing bowel symptoms and SIBO.
Compare D; Pica L; Rocco A; De Giorgi F; Cuomo R; Sarnelli G; Romano M; Nardone G
Eur J Clin Invest; 2011 Apr; 41(4):380-6. PubMed ID: 21128930
[TBL] [Abstract][Full Text] [Related]
6. Nucleotide supplementation: a randomised double-blind placebo controlled trial of IntestAidIB in people with Irritable Bowel Syndrome [ISRCTN67764449].
Dancey CP; Attree EA; Brown KF
Nutr J; 2006 Jun; 5():16. PubMed ID: 16762076
[TBL] [Abstract][Full Text] [Related]
7. Dose-response study of probiotic bacteria Bifidobacterium animalis subsp lactis BB-12 and Lactobacillus paracasei subsp paracasei CRL-341 in healthy young adults.
Larsen CN; Nielsen S; Kaestel P; Brockmann E; Bennedsen M; Christensen HR; Eskesen DC; Jacobsen BL; Michaelsen KF
Eur J Clin Nutr; 2006 Nov; 60(11):1284-93. PubMed ID: 16721394
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Lactobacillus paracasei sub. paracasei F19 on abdominal symptoms in patients with symptomatic uncomplicated diverticular disease: a pilot study.
Annibale B; Maconi G; Lahner E; De Giorgi F; Cuomo R
Minerva Gastroenterol Dietol; 2011 Mar; 57(1):13-22. PubMed ID: 21372765
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of pantoprazole delayed-release granules for oral suspension in a placebo-controlled treatment-withdrawal study in infants 1-11 months old with symptomatic GERD.
Winter H; Kum-Nji P; Mahomedy SH; Kierkus J; Hinz M; Li H; Maguire MK; Comer GM
J Pediatr Gastroenterol Nutr; 2010 Jun; 50(6):609-18. PubMed ID: 20400912
[TBL] [Abstract][Full Text] [Related]
10. Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease.
Orenstein SR; Hassall E; Furmaga-Jablonska W; Atkinson S; Raanan M
J Pediatr; 2009 Apr; 154(4):514-520.e4. PubMed ID: 19054529
[TBL] [Abstract][Full Text] [Related]
11. Randomised clinical trial: sustained response to PPI treatment of symptoms resembling functional dyspepsia and irritable bowel syndrome in patients suffering from an overlap with erosive gastro-oesophageal reflux disease.
Mönnikes H; Schwan T; van Rensburg C; Straszak A; Theek C; Sander P; Lühmann R
Aliment Pharmacol Ther; 2012 Jun; 35(11):1279-89. PubMed ID: 22486552
[TBL] [Abstract][Full Text] [Related]
12. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
[TBL] [Abstract][Full Text] [Related]
13. Treatment and secondary prevention effects of the probiotics Lactobacillus paracasei or Bifidobacterium lactis on early infant eczema: randomized controlled trial with follow-up until age 3 years.
Gore C; Custovic A; Tannock GW; Munro K; Kerry G; Johnson K; Peterson C; Morris J; Chaloner C; Murray CS; Woodcock A
Clin Exp Allergy; 2012 Jan; 42(1):112-22. PubMed ID: 22092692
[TBL] [Abstract][Full Text] [Related]
14. A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating.
Kim HJ; Vazquez Roque MI; Camilleri M; Stephens D; Burton DD; Baxter K; Thomforde G; Zinsmeister AR
Neurogastroenterol Motil; 2005 Oct; 17(5):687-96. PubMed ID: 16185307
[TBL] [Abstract][Full Text] [Related]
15. Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Evaluate the Benefit of the Probiotic Bifidobacterium infantis 35624 in Non-Patients With Symptoms of Abdominal Discomfort and Bloating.
Ringel-Kulka T; McRorie J; Ringel Y
Am J Gastroenterol; 2017 Jan; 112(1):145-151. PubMed ID: 27845337
[TBL] [Abstract][Full Text] [Related]
16. Clinical trial: the effects of a fermented milk containing three probiotic bacteria in patients with irritable bowel syndrome - a randomized, double-blind, controlled study.
Simrén M; Ohman L; Olsson J; Svensson U; Ohlson K; Posserud I; Strid H
Aliment Pharmacol Ther; 2010 Jan; 31(2):218-27. PubMed ID: 19863495
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of
Lewis ED; Antony JM; Crowley DC; Piano A; Bhardwaj R; Tompkins TA; Evans M
Nutrients; 2020 Apr; 12(4):. PubMed ID: 32326347
[TBL] [Abstract][Full Text] [Related]
18. Prescript-Assist probiotic-prebiotic treatment for irritable bowel syndrome: a methodologically oriented, 2-week, randomized, placebo-controlled, double-blind clinical study.
Bittner AC; Croffut RM; Stranahan MC
Clin Ther; 2005 Jun; 27(6):755-61. PubMed ID: 16117982
[TBL] [Abstract][Full Text] [Related]
19. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
Drouault-Holowacz S; Bieuvelet S; Burckel A; Cazaubiel M; Dray X; Marteau P
Gastroenterol Clin Biol; 2008 Feb; 32(2):147-52. PubMed ID: 18387426
[TBL] [Abstract][Full Text] [Related]
20. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota.
Kajander K; Myllyluoma E; Rajilić-Stojanović M; Kyrönpalo S; Rasmussen M; Järvenpää S; Zoetendal EG; de Vos WM; Vapaatalo H; Korpela R
Aliment Pharmacol Ther; 2008 Jan; 27(1):48-57. PubMed ID: 17919270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]